Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Valeant to buy dermatogy firm Medicis

September 4, 2012 Sales and Marketing Valeant

Speciality pharma company Valeant is to acquire dermatology-focused Medicis for $2.6 billion.Medicis’ portfolio includes ‘cosmaceutical’ prescription brands such as Solodyn, …
News

New quad HIV pill passed by FDA

September 2, 2012 Sales and Marketing FDA, Gilead, HIV, stribild

Gilead’s four-in-one anti-HIV once-daily pill Stribild has been given the green light by the FDA for adults who have not …
News

J&J buys into Genmab cancer drug

August 31, 2012 Sales and Marketing Cancer, Genmab, Janssen Cilag, Janssen-Cilag, Johnson & Johnson, multiple myeloma

Danish biotech company Genmab has sold the worldwide rights for one of its cancer drugs to Johnson & Johnson-owned Janssen …
News

ABPI worried by public ignorance about medicines

August 31, 2012 Sales and Marketing ABPI, UK

People in the UK are misinformed about how much medicines cost to discover, develop and launch, according to a new …
News

Patient death halts BMS hep C trial

August 30, 2012 Sales and Marketing BMS, HCV, hepatitis C

Bristol-Myers Squibb has admitted that the death of a patient was behind its decision to stop development of a potential …
News

Genzyme ‘confident’ of FDA nod for MS drug

August 29, 2012 Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis

Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …
News

Innovation scorecard gets ABPI thumbs-up

August 29, 2012 Sales and Marketing NHS, NICE, market access

 An NHS ‘innovation scorecard’, showing which hospitals in England are using NICE-approved drugs – and which aren’t – has been …
News

AstraZeneca poaches Soirot from Roche to be new chief executive

August 28, 2012 Sales and Marketing AstraZeneca, Soirot

AstraZeneca has poached Roche’s head of pharma, Pascal Soriot, to be its new chief executive. He joins on 1 October. …
News

Novartis’ myelofibrosis treatment approved in Europe

August 28, 2012 Sales and Marketing Incyte, Jakavi, Novartis, Orphan Drugs, myelofibrosis

Novartis’ Jakavi, a new treatment for patients with myelofibrosis has been approved in Europe. The drug was co-developed with Incyte, …
News

Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring

August 25, 2012 Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance

Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …
News

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012 Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …
News

Indian reps strike over pharma’s bad ethics

August 24, 2012 Sales and Marketing FMRAI, India, pharma, reps

Pharma reps in India have gone on strike to highlight what they see as the corrupt nature of the pharma …
News

NHS must tackle ‘tsunami of bureaucracy’

August 24, 2012 Sales and Marketing CCGs, Farrar, NHS, reforms

The NHS Confederation has expressed concerns that the government’s reform of the health service will lead to a ‘tsunami of …
News

Pfizer and Mylan sign Japanese generics deal

August 23, 2012 Sales and Marketing Mylan, Pfizer, generics

Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …
News

Novartis’ Indian patent case delayed

August 23, 2012 Sales and Marketing Glivec, MSF, Novartis, generics

Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026